ArticleScientific reports2018

Distribution-based measures of tumor heterogeneity are sensitive to mutation calling and lack strong clinical predictive power.

Javad Noorbakhsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.